Bio Business
Braving the IPO Drought
Braving the IPO Drought
Megan Scudellari | Mar 1, 2012
Despite nervous investors and a volatile market, a courageous few biotechnology companies are taking their chances on Wall Street.
Bioterrorist Battles
Fran Hawthorne | Jan 1, 2012
A Swiss-based firm may have a back-door way to thwart a bioterrorist attack—by fighting the flu.
New Tech Boosts Science
Tia Ghose | Oct 1, 2011
From iPhone apps to cloud computing, everyday digital technologies are helping advance drug discovery, conduct clinical trials, and improve medical care.
Make Mine Rare
Make Mine Rare
Megan Scudellari | Aug 1, 2011
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
Take Two of These
Take Two of These
Bob Grant | Jun 22, 2011
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
Teaching an Old Drug New Tricks
Megan Scudellari | Apr 1, 2011
Biotech companies hope to turn the practice of finding novel uses for existing compounds into big business.
Alternative Agriculture
Vanessa Schipani | Feb 1, 2011
The debate over genetically engineered crops rages on, but other technologies offer new hope for sustainable farming.
The Profits of Nonprofit
Megan Scudellari | Jan 1, 2011
The surprising results when drug development and altruism collide